Evidence map›Paper›PMID 39884360›Full record

ArticleVirologica Sinica2025

Evaluating the performance of the PREDAC method in flu vaccine recommendations over the past decade (2013-2023).

Yousong Peng, Lei Yang, Weijuan Huang, Mi Liu, Xiao Ding, Xiangjun Du, Yuelong Shu, Taijiao Jiang, Dayan Wang

Erratum issuedAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Virologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yousong PengBioinformatics Center, College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Hunan University, Changsha, 410082, China.
Lei YangNational Institute for Viral Disease Control and Prevention, China CDC, Beijing, 102206, China.
Weijuan HuangNational Institute for Viral Disease Control and Prevention, China CDC, Beijing, 102206, China.
Mi LiuJiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Xiao DingSuzhou Institute of Systems Medicine, Suzhou, 215123, China.
Xiangjun DuDepartment of Biostatistics and Systems Biology, School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, 510275, China.
Yuelong ShuKey Laboratory of Pathogen Infection Prevention and Control (MOE), State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 102629, China. Electronic address: yshu@cnic.org.cn.
Taijiao JiangGuangzhou National Laboratory, Guangzhou, 510005, China. Electronic address: jiang_taijiao@gzlab.ac.cn.
Dayan WangNational Institute for Viral Disease Control and Prevention, China CDC, Beijing, 102206, China. Electronic address: dayanwang@cnic.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39884360
PMCPMC12130999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.